NCT04134065 is a EARLY_PHASE1 clinical trial of Vitamin D in Vitamin D Deficiency, sponsored by Nanjing University School of Medicine.

Who is sponsoring NCT04134065?

NCT04134065 is sponsored by Nanjing University School of Medicine.

What drugs are being tested in NCT04134065?

Interventions in NCT04134065: Vitamin D, Placebo oral capsule.

What condition does NCT04134065 study?

NCT04134065 studies Vitamin D Deficiency, Crohn Disease.

Is NCT04134065 still recruiting?

NCT04134065 is currently status unknown. Last updated 21 October 2019.

Last reviewed 2019-10-21 · How we verify

NCT04134065

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Effect of Vitamin D in Crohn's Disease

Status unknown EARLY_PHASE1 Last updated 21 October 2019

What this trial tests

EARLY_PHASE1 trial testing Vitamin D in Vitamin D Deficiency in 30 participants. Status unknown.

Timeline

1 December 2019

Primary endpoint
31 October 2020

31 December 2020

Quick facts

Lead sponsor	Nanjing University School of Medicine
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	30
Start date	1 December 2019
Primary completion	31 October 2020
Estimated completion	31 December 2020

Drugs / interventions tested

Vitamin D
Placebo oral capsule

Conditions studied

Vitamin D Deficiency — all drugs for Vitamin D Deficiency →
Crohn Disease — all drugs for Crohn Disease →

Sponsor

Nanjing University School of Medicine

Who can join

Adults 20 to 60, any sex, with Vitamin D Deficiency or Crohn Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy and safety of 12-week goal-directed therapy in the treatment of refractory inflammatory patients, and to initially explore treatment options. Patients with potential risk factors for recurrence after surgery for Crohn's disease and a serum 25(OH)D concentration \<75 nmol/L were prescribed oral liquid vitamin D supplementation over 12 weeks using a specific protocol with dose adjusted 4-weekly to aim for a target level of 100-125 nmol/L.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the "Bile Acid Code".
Gadaleta RM, Cariello M, Crudele L, Moschetta A. · · 2022 · cited 39× · PMID 35956388 · DOI 10.3390/nu14153212
Vitamin D for the treatment of inflammatory bowel disease.
Wallace C, Gordon M, Sinopoulou V, Limketkai BN. · · 2023 · cited 17× · PMID 37781953 · DOI 10.1002/14651858.cd011806.pub2

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

NCT07366086 — Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta · Phase 3 · recruiting
NCT07458815 — Vitamin D for Acute Intracerebral Hemorrhage · NA · not yet recruiting
NCT07491965 — Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency . · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07293910 — Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py · Phase 2 · recruiting

Other recruiting trials for Vitamin D Deficiency

Currently open trials in the same condition.

NCT07317830 — Effects of Different Vitamin D3 Formulations in Vitamin D-Deficient Adults · NA · recruiting
NCT07366970 — Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? · NA · recruiting
NCT07481240 — A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families · NA · recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting
NCT07200011 — Effect of Vitamin D on the Clinical and Radiographic of Unsplinted Mandibular Implant Overdentures · active not recruiting

Other Nanjing University School of Medicine trials

Trials by the same sponsor.

NCT06285279 — The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases · Phase 1 · recruiting
NCT06226896 — Effects of Dapagliflozin on Progression of Alport Syndrome · active not recruiting
NCT05863936 — Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis · Phase 3 · unknown
NCT06376214 — Daratumumab for Patients With Light Chain Amyloidosis · NA · recruiting
NCT04507945 — Stablishment of Prevention and Treatment System for Intestinal Dysfunction · Phase 1, PHASE2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04134065 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanjing University School of Medicine
Last refreshed: 21 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04134065.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing